Newsroom
September 7, 2016
As they age, individuals living with HIV are at greater risk of developing heart disease and other chronic health conditions due to HIV-associated inflammation as well as the medications that control the virus.
September 6, 2016
Patients receiving life-saving, anti-retroviral treatment for HIV are living longer and healthier lives. But there is a downside: As they age, individuals living with HIV are at greater risk of developing heart disease and other chronic health conditions due to HIV-associated inflammation as well as the medications that control the virus. This can pose special problems for patients who live in lower- and middle-income Latin American countries, such as Mexico and the Dominican Republic, where resources for primary care are limited, according to a new study in the August edition of the journal PLOS ONE.
September 1, 2016
Starting newly-diagnosed diabetes patients on the triple combination of metformin/pioglitazone/exenatide upfront provided better glucose control with less hypoglycemia than a standard sequential regimen, 3-year follow-up from the EDICT trial showed. Read the full story at MedPage Today
August 20, 2016
Dapagliflozin improves insulin sensitivity and increases lipid oxidation and plasma ketone concentration in patients with type 2 diabetes, according to a study published online Aug. 25 in Diabetes Care. Read the full story at Endocrinology Advisor
August 10, 2016
Middle-age spread is not only unattractive and a risk factor for developing type 2 diabetes. Read the full story at EndocrineWeb
June 27, 2016
During the summer months, various factors may result in ED visits by asthmatics and diabetics, said Rosemarie Ramos, Ph.D., M.P.H., of the School of Medicine at the Health Science Center.
